|
|
Article: Pomegranate juice.(NUTRACEUTICALS RESEARCH)(myocardial ischemia)(Brief Article)
- Article from:
- Nutraceuticals World
- Article date:
- December 1, 2005
CopyrightCOPYRIGHT 2005 Rodman Publishing. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Nutraceutical: Pomegranate juice
Indication: Ischemic coronary heart disease (CHD)
Source: Am J Cardiol, September 15, 2005;96(6):810-4.
Research: Pomegranate juice contains antioxidants and may have antiatherosclerotic properties. However, no study has investigated the effects of pomegranate juice on patients who have ischemic coronary heart disease (CHD). Researchers investigated whether daily consumption of pomegranate juice for three months would affect myocardial perfusion in 45 patients who had CHD and myocardial ischemia in a randomized, placebo-controlled, double-blind study. Patients were randomly assigned into one of two groups: a ...